Genetic screening of oncogenic drivers in squamous cell carcinoma

Genetic screening of oncogenic drivers in squamous cell carcinoma - Genetic screening of oncogenic drivers in squamous cell carcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000022030

Enrollment

200

Registered

2016-05-01

Start date

2016-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Squamous cell carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients diagnosed with lung squamous cell carcinoma, esophageal cancer, or head and neck carcinoma 2) To have a formalin-fixed paraffin embedded tissues for genetic analysis. However, patients with insufficient amount of tissue is allowable. 3) Informed consent for the study 4) Patients with existing anticancer treatment is allowable

Exclusion criteria

Exclusion criteria: 1) Patients who are not possible subjects of anticancer drug treatment

Design outcomes

Primary

Measure	Time frame
To evaluate the detected frequency of a FGFR alteration in squamous cell carcinoma	—

Countries

Japan

Contacts

Public ContactSakai Kazuko

Kindai University Faculty of Medicine Department of Genome Biology

kasakai@med.kindai.ac.jp072-366-0221

Outcome results